Stan Smith
Direktor/Vorstandsmitglied bei MAIA BIOTECHNOLOGY, INC.
Vermögen: 5 Mio $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Stan Smith
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Stan Smith
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| THE TAIWAN FUND, INC. | Investment Trusts/Mutual Funds | Corporate Secretary | |
| GERON CORPORATION | Biotechnology | Corporate Officer/Principal | |
| AVADIM HEALTH, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Boston University | College/University | Undergraduate Degree | |
HSBC Global Asset Management (Taiwan) Ltd.
 HSBC Global Asset Management (Taiwan) Ltd. Investment ManagersFinance HSBC Global Asset Management (Taiwan) Ltd. (HSBC-GAM Taiwan) is the wholly-owned asset management subsidiary of HSBC Global Asset Management (UK) Ltd., ultimately held by HSBC Holdings Plc (LSE: HSBA; ADR: HSBC) in Great Britain. HSBC-GAM Taiwan, previously known as HSBC Investments (Taiwan) Ltd., was established in 1986 as CSITC-China Securities Investment Trust Corp. The firm became part of HSBC in 2001 and is located in Taipei, Taiwan. | Investment Managers | Chief Operating Officer | |
| Indiana University of Pennsylvania | College/University | Undergraduate Degree | |
| The Pennsylvania State University | College/University | Masters Business Admin | |
| University of Illinois | College/University | Undergraduate Degree | |
| University of Montréal | College/University | Graduate Degree | |
| University of South Carolina | College/University | Masters Business Admin | |
| Moscow State University Lomonosov | College/University | Doctorate Degree | |
| University of Innsbruck | College/University | Graduate Degree | |
| HEC Montréal | College/University | Masters Business Admin | |
| Microtech Knives, Inc. | Home Furnishings | Director of Finance/CFO | |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
| TRANSUNION | Financial Publishing/Services | Corporate Officer/Principal | |
| Iuliu Hatieganu University of Medicine & Pharmacy | College/University | Doctorate Degree | |
| St. Mary's University School of Law | College/University | Graduate Degree | |
360Medlink, Inc.
 360Medlink, Inc. Packaged SoftwareTechnology Services 360Medlink, Inc. operates as a software company which creates custom mobile and tablet innovations for healthcare and biotechnology organizations. The firm also offers software solutions to pharmaceutical marketing, medical affairs, and global clinical trials. The company is headquartered in Montreal, Canada. | Packaged Software | Chief Executive Officer | |
Springcoin, Inc.
 Springcoin, Inc. Packaged SoftwareTechnology Services Springcoin, Inc. develops software. It builds transparent and secure ecosystem to exchange credit and identity information using the block chain. The company was founded by Adam Navroz Jiwan, Anna Fridman and John Sun in 2017 and is headquartered in Marina Del Rey, CA. | Packaged Software | Director/Board Member | |
| Babes-Bolyai University | College/University | Undergraduate Degree | |
DGD Pharmaceuticals Corp.
 DGD Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology DGD Pharmaceuticals engages in the development of drug for cancer therapies. It offers DGD1202, targets cancer cell and help prevent to mutate into EGFR. The company was founded by Mukesh Nyati and is headquartered in Chicago, IL. | Pharmaceuticals: Major | Chief Executive Officer | |
| Universidad Metropolitana De Monterrey | College/University | Graduate Degree | |
| Imperio, Inc. | Chief Executive Officer | ||
| Optimus Realty, Inc. | Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 18 |
| Kanada | 5 |
| Rumänien | 3 |
| Israel | 2 |
| Taiwan | 2 |
Sektoral
| Consumer Services | 15 |
| Health Technology | 6 |
| Miscellaneous | 3 |
| Technology Services | 3 |
| Finance | 2 |
Operativ
| Director/Board Member | 7 |
| Chief Executive Officer | 6 |
| Graduate Degree | 5 |
| Undergraduate Degree | 5 |
| Independent Dir/Board Member | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Stan Smith
- Unternehmensverbindungen
